索宝蛋白(603231) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 was RMB 383.09 million, a decrease of 13.15% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was RMB 20.88 million, a significant decrease of 51.95% year-over-year[3] - Net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was RMB 17.82 million, down 59.61% compared to the same period last year[3] - Basic earnings per share (EPS) for Q3 2024 was RMB 0.11, a decrease of 63.33% year-over-year[3] - Total operating income for the first three quarters of 2024 was 1,155,092,649.30, a decrease from 1,288,623,299.75 in the same period of 2023[14] - Net profit for the first three quarters of 2024 was 91,680,531.08, down from 115,689,096.97 in the same period of 2023[16] - Net profit attributable to parent company shareholders was RMB 91.68 million, a decrease of 20.7% compared to RMB 115.69 million in the same period last year[17] - Basic earnings per share (EPS) was RMB 0.48, down 40.7% from RMB 0.81 in the same period last year[17] - Revenue from sales of goods and services was RMB 1.23 billion, a decrease of 8.1% compared to RMB 1.34 billion in the same period last year[18] Cash Flow and Liquidity - Operating cash flow for the first nine months of 2024 was RMB 118.12 million, down 24.35% compared to the same period last year[3] - Cash flow from operating activities was RMB 118.12 million, a decrease of 24.4% compared to RMB 156.15 million in the same period last year[18] - Cash flow from investing activities was negative RMB 760.66 million, a significant increase in outflow compared to negative RMB 119.67 million in the same period last year[19] - Cash flow from financing activities was negative RMB 249.14 million, a substantial increase in outflow compared to negative RMB 47.96 million in the same period last year[19] - Cash and cash equivalents at the end of the period were RMB 184.01 million, a decrease of 82.8% compared to RMB 1.07 billion at the beginning of the period[19] - Payments for goods and services were RMB 1.04 billion, a decrease of 8.1% compared to RMB 1.13 billion in the same period last year[18] - Tax refunds received were RMB 53.07 million, an increase of 11.2% compared to RMB 47.71 million in the same period last year[18] - Payments for employee compensation were RMB 73.06 million, a slight increase of 0.7% compared to RMB 72.55 million in the same period last year[18] Assets and Liabilities - Total assets as of the end of Q3 2024 were RMB 2.03 billion, a decrease of 7.03% compared to the end of the previous year[3] - Total assets decreased to 2,032,148,853.44 from 2,185,778,622.48 compared to the previous period[13] - Total liabilities decreased to 187,222,944.97 from 252,211,492.59 compared to the previous period[14] - Shareholders' equity increased to 1,844,925,908.47 from 1,933,567,129.89 compared to the previous period[14] - Monetary funds as of September 30, 2024, amount to 1,073,149,114.80 RMB[12] - Accounts receivable as of September 30, 2024, amount to 174,670,898.16 RMB[12] - Inventory as of September 30, 2024, amount to 215,138,307.96 RMB[12] - Total current assets as of September 30, 2024, amount to 1,488,805,031.41 RMB[12] - Fixed assets as of September 30, 2024, amount to 605,532,724.01 RMB[12] - Construction in progress as of September 30, 2024, amount to 10,332,660.14 RMB[12] Profitability and Returns - The company's weighted average return on equity (ROE) for Q3 2024 was 1.14%, a decrease of 3.68 percentage points compared to the same period last year[3] - Non-recurring gains and losses for the first nine months of 2024 amounted to RMB 3.06 million, primarily due to government subsidies and financial asset gains[5][6] - The decrease in net profit was mainly due to a decline in product and raw material prices, with product prices falling more than raw material prices[8] - The decline in EPS was attributed to both the decrease in net profit and the increase in share capital following the company's initial public offering[8] - Financial expenses showed a significant improvement, with a net gain of 7,629,563.05 in the first three quarters of 2024 compared to a net loss of 35,687.53 in the same period of 2023[16] - Other income increased to 14,966,791.57 in the first three quarters of 2024 from 10,146,852.98 in the same period of 2023[16] - Investment income rose to 7,085,298.38 in the first three quarters of 2024 from 348,439.53 in the same period of 2023[16] Shareholder Information - Total number of ordinary shareholders at the end of the reporting period is 22,302[9] - Shandong Wonderful Industrial Group Co., Ltd. holds 82,748,091 shares, representing 43.22% of total shares[9] - Jinan Caijin Fosun Weishi Equity Investment Fund Partnership holds 13,473,046 shares, representing 7.04% of total shares[9] - Bunge (Shanghai) Management Co., Ltd. holds 7,179,715 shares, representing 3.75% of total shares[9] Operating Costs and Expenses - Operating costs for the first three quarters of 2024 were 1,073,407,161.58, a decrease from 1,157,315,186.85 in the same period of 2023[16] - R&D expenses increased to 8,089,606.75 in the first three quarters of 2024 from 7,330,670.29 in the same period of 2023[16]